Innovating the NICU: AI Predictive Analytics, Parent-Facing Technology, and Team-Centered Care
10:45AM - 11:30AM
SeqFirst in Practice: Advancing Genomic Diagnosis Through Early Sequencing
This session introduces the SeqFirst initiative, outlining its goals and rationale for integrating early genomic sequencing into clinical care. Attendees will explore the workflows, infrastructure, and interdisciplinary collaboration needed for successful implementation, review the evidence supporting its clinical utility, and gain practical insights from lessons learned by early SeqFirst programs.
Learning Objectives:
Explain the core goals and rationale behind the SeqFirst initiative
Discuss the workflow, infrastructure, and interdisciplinary collaboration required to implement SeqFirst
Summarize the evidence supporting SeqFirst’s clinical utility
Apply lessons learned from early SeqFirst programs
Presented by:
Michael J Bamshad, M.D., Professor and Head, Division of Genetic Medicine, Allan and Phyllis Treuer Endowed Chair in Genetics and Development - Department of Pediatrics, University of Washington & Seattle Children’s Hospital
11:30AM - 12:15AM
Rethinking ROP Screening: Reducing Burden While Preventing Avoidable Blindness
This session examines the challenges of current retinopathy of prematurity (ROP) screening practices, highlighting the significant time, stress, and resource burden associated with frequent examinations. Attendees will explore why preventable ROP-related blindness still occurs, review data showing that most exams do not alter management and discuss emerging strategies to optimize screening while maintaining patient safety and vision outcomes.
Learning Objectives:
ROP examinations are time consuming and stressful (for everyone involved)
Blindness from ROP is nearly always avoidable, but an estimated 500 babies per year continue to go blind in the US (and many more worldwide)
95% of babies will not develop ROP that requires treatment, which means that close to 98-99% of exams do not change management.
Presented by:
Peter Campbell, M.D., M.P.H., Professor of Ophthalmology - Casey Eye Institute, Oregon Health & Science University (OHSU)